Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapagliflozin with or without saxagliptin versus placebo in adults with type 2 diabetes mellitus and CKD with albuminuria
2015-002676-24Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) and chronic kidney disease (CKD) comparing Dapagliflozin + saxagliptin, Dapagliflozin and Placebo (3 arms). Started Oct 2015; status: completed.
02
Drugs
dapagliflozinsaxagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)chronic kidney disease (CKD)
Beyond the preview
Go deeper on 2015-002676-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-002676-24.